Utilizamos cookies

Este sitio web utiliza cookies propias y de terceros para mantener la sesión, ofrecerle una mejor experiencia de usuario y obtener datos estadísticos de navegación de los usuarios. Para más información vea la Política de cookies.

ESTUDIO ENF INFECCIOSAS - Prisma - Unidad de Bibliometría

ESTUDIO ENFERMEDADES INFECCIOSAS Y QUIMIOTERAPIA - CTS-154 (ESTUDIO ENF INFECCIOSAS)

Tipo de colectivo: Grupo de investigación
Estado: Grupo definitivo
Ámbito: Andalucía
Instituciones: Sistema Sanitario Público de Andalucía. Fundación Pública Andaluza para la Gestión de la Investigación en Salud de Sevilla (FISEVI)
Fecha de creación: 01/01/1990

Investiga en

Palabras clave
Líneas de investigación
Resumen
Nombre Rol
Merchante Gutierrez, Nicolas Miembro
Tipo Año Título Fuente
Artículo2024 Role of rectal colonization by third-generation cephalosporin-resistant Enterobacterales on the risk of surgical site infection after hepato-pancreato-biliary surgery MICROBIOLOGY SPECTRUM
Artículo2023 Role of IP-10 to predict clinical progression and response to IL-6 blockade with sarilumab in early COVID-19 pneumonia. A subanalysis of the SARICOR clinical trial OPEN FORUM INFECTIOUS DISEASES
Artículo2023 Role of previous systemic antibiotic therapy on the probability of recurrence after an initial episode of Clostridioides difficile infection treated with vancomycin. JAC-antimicrobial resistance
Editorial2022 Community-acquired pneumonia – An EFIM guideline critical appraisal adaptation for internists EUROPEAN JOURNAL OF INTERNAL MEDICINE
Artículo2022 Early use of Sarilumab in patients hospitalised with COVID-19 pneumonia and features of systemic inflammation. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2022 Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: An individual patient data meta-analysis GUT
Artículo2022 High incidence of asymptomatic phase I IgG seroconversion after acute Q fever episode: implications for chronic Q fever diagnosis. CLINICAL INFECTIOUS DISEASES
Artículo2022 Impact of COVID19 pandemic on the incidence of health-care associated Clostridioides difficile infection. ANAEROBE
Artículo2022 Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors: a Spanish nationwide cohort HIV MEDICINE
Artículo2022 Study protocol for a randomized clinical trial to assess 7 versus 14-days of treatment for Pseudomonas aeruginosa bloodstream infections (SHORTEN-2 trial) PLOS ONE
Artículo2021 Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Artículo2021 COVID-19 in hospitalized HIV-positive and HIV-negative patients: a matched study HIV MEDICINE
Artículo2021 How do women living with HIV experience menopause? Menopausal symptoms, anxiety and depression according to reproductive age in a multicenter cohort BMC WOMENS HEALTH
Artículo2021 Prediction of liver stiffness by serum indexes in HCV-infected patients with or without HIV coinfection MEDICINE
Artículo2021 Reply to Giannini et al. CLINICAL INFECTIOUS DISEASES
Artículo2020 Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain CLINICAL MICROBIOLOGY AND INFECTION
Artículo2020 Effectiveness of the combination elvitegravir/cobicistat/tenofovir/emtricitabine (EVG/COB/TFV/FTC) plus darunavir among treatment-experienced patients in clinical practice: A multicentre cohort study AIDS RESEARCH AND THERAPY
Artículo2020 Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study LANCET HIV
Artículo2020 Efficacy and safety of early treatment with sarilumab in hospitalised adults with COVID-19 presenting cytokine release syndrome (SARICOR STUDY): Protocol of a phase II, open-label, randomised, multicentre, controlled clinical trial BMJ OPEN
Artículo2020 Executive summary: Consensus document of GEHEP of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), along with SOCIDROGALCOHOL, SEPD and SOMAPA on hepatitis C virus infection management in drug users Enfermedades infecciosas y microbiología clínica
Otros2020 Executive summary: Consensus document of the diagnosis, management and prevention of infection with the hepatitis E virus: Study Group for Viral Hepatitis (GEHEP) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) Enfermedades infecciosas y microbiología clínica
Artículo2020 Impact of HIV on the survival of hepatocellular carcinoma in hepatitis C virus-infected patients AIDS
Artículo2020 Liver stiffness at the time of sustained virological response predicts the clinical outcome in people living with human immunodeficiency virus and hepatitis C virus with advanced fibrosis treated with direct-acting antivirals CLINICAL INFECTIOUS DISEASES
Artículo2020 Prediction of Esophageal Varices by Liver Stiffness and Platelets in Persons With Human Immunodeficiency Virus Infection and Compensated Advanced Chronic Liver Disease CLINICAL INFECTIOUS DISEASES
Artículo2020 Recommendations for the diagnosis and treatment of clostridioides difficile infection: an official clinical practice guideline of the Spanish Society of Chemotherapy (SEQ), Spanish Society of Internal Medicine (SEMI) and the working group of postoperative infection of the Spanish Society of Anesthesia and Reanimation (SEDAR) Revista Española de Quimioterapia
Revisión2020 Screening for Hepatocellular Carcinoma in HIV-Infected Patients: Current Evidence and Controversies Current HIV/AIDS Reports
Artículo2020 Similar prevalence of hepatic steatosis among patients with chronic hepatitis C with and without HIV coinfection Scientific reports
Artículo2019 Early emergence of opportunistic infections after starting direct-acting antiviral drugs in HIV/HCV-coinfected patients JOURNAL OF VIRAL HEPATITIS
Artículo2019 Genetic markers of lipid metabolism genes associated with low susceptibility to HCV infection Scientific reports
Artículo2019 Influence of HIV infection on the natural history of hepatocellular carcinoma: results from a global multicohort study JOURNAL OF CLINICAL ONCOLOGY
Artículo2019 Low performance of ultrasound surveillance for the diagnosis of hepatocellular carcinoma in HIV-infected patients AIDS
Artículo2019 Similar recovery of liver function after response to all-oral HCV therapy in patients with cirrhosis with and without HIV coinfection JOURNAL OF VIRAL HEPATITIS
Artículo2018 Bacterial translocation and clinical progression of HCV-related cirrhosis in HIV-infected patients JOURNAL OF VIRAL HEPATITIS
Artículo2018 Baseline resistance-guided therapy does not enhance the response to interferon-free treatment of HCV infection in real life Scientific reports
Artículo2018 Hepatocellular carcinoma after sustained virological response with interferon-free regimens in HIV/hepatitis C virus-coinfected patients AIDS
Artículo2018 Impact of interferon-free regimens on the glomerular filtration rate during treatment of chronic hepatitis C in a real-life cohort JOURNAL OF VIRAL HEPATITIS
Artículo2018 Sustained virological response to direct-acting antiviral regimens reduces the risk of hepatocellular carcinoma in HIV/HCV-coinfected patients with cirrhosis JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2017 Changes in liver steatosis after switching from efavirenz to raltegravir among human immunodeficiency virus-infected patients with nonalcoholic fatty liver disease CLINICAL INFECTIOUS DISEASES
Artículo2017 Fat mass and obesity-associated gene variations are related to fatty liver disease in HIV-infected patients HIV MEDICINE
Artículo2017 High frequency of potential interactions between direct-acting antivirals and concomitant therapy in HIV/hepatitis C virus-coinfected patients in clinical practice HIV MEDICINE
Artículo2017 Liver stiffness predicts variceal bleeding in HIV/HCV-coinfected patients with compensated cirrhosis AIDS
Letter2017 Low incidence of acute hepatitis C virus infection among Southern Spanish HIV-infected individuals JOURNAL OF INFECTION
Artículo2017 Real-life experience with sorafenib for the treatment of hepatocellular carcinoma in HIV-infected patients AIDS
Artículo2017 Week 4 response predicts sustained virological response to all-oral direct-acting antiviral-based therapy in cirrhotic patients with hepatitis C virus genotype 3 infection CLINICAL MICROBIOLOGY AND INFECTION
Artículo2016 Changes in liver steatosis evaluated by transient elastography with the controlled attenuation parameter in HIV-infected patients HIV MEDICINE
Artículo2016 Changes in the response to treatment against chronic hepatitis C between 1999 and 2015: data from a prospective cohort EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
Artículo2016 The PNPLA3 genetic variant rs738409 influences the progression to cirrhosis in HIV/Hepatitis C virus coinfected patients PLOS ONE
Artículo2015 Hepatitis C virus reinfection after sustained virological response in HIV-infected patients with chronic hepatitis C JOURNAL OF INFECTION
Artículo2015 High prevalence of antibodies against hepatitis E virus in HIV-infected patients with unexplained liver disease Enfermedades infecciosas y microbiología clínica
Artículo2015 Impact of genetic polymorphisms associated with nonalcoholic fatty liver disease on HIV-infected individuals AIDS
Artículo2015 Impact of HIV infection on sustained virological response to treatment against hepatitis C virus with pegylated interferon plus ribavirin EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
Artículo2015 Low risk of liver decompensation among human immunodeficiency virus/hepatitis C virus-coinfected patients with mild fibrosis in the short term HEPATOLOGY
Revisión2015 News on HIV-HCV Coinfection: Update From the 2015 GEHEP Conference AIDS REVIEWS
Artículo2015 Progression of liver stiffness predicts clinical events in HIV/HCV-coinfected patients with compensated cirrhosis BMC INFECTIOUS DISEASES
Artículo2014 HIV/hepatitis C virus-coinfected patients who achieved sustained virological response are still at risk of developing hepatocellular carcinoma AIDS
Artículo2014 Incidence and natural history of hepatitis E virus coinfection among HIV-infected patients AIDS
Revisión2014 Latest pharmacotherapy options for treating hepatitis C in HIV-infected patients EXPERT OPINION ON PHARMACOTHERAPY
Artículo2014 Reassessment of genotype 1 hepatitis C virus subtype misclassification by LiPA 2.0: implications for direct-acting antiviral treatment JOURNAL OF CLINICAL MICROBIOLOGY
Artículo2013 Benefits from sustained virologic response to pegylated interferon plus ribavirin in HIV/Hepatitis C virus-coinfected patients with compensated cirrhosis CLINICAL INFECTIOUS DISEASES
Corrección2013 Coexistence of pyoderma gangrenosum and Sweet's syndrome in a patient with ulcerative colitis (vol 102, pg 2865, 2007) AMERICAN JOURNAL OF GASTROENTEROLOGY
Artículo2013 Incidence of liver damage of uncertain origin in HIV patients not co-infected with HCV/HBV PLOS ONE
Artículo2013 Increasing incidence of hepatocellular carcinoma in HIV-infected patients in Spain CLINICAL INFECTIOUS DISEASES
Artículo2012 Efficacy of chronic hepatitis C therapy with pegylated interferon and ribavirin in patients on methadone maintenance treatment EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
Artículo2012 Hepatic steatosis and steatohepatitis in human immunodeficiency virus/hepatitis C virus-coinfected patients HEPATOLOGY
Artículo2012 HIV-coinfection leads to a modest increase in plasma HCV-RNA load in patients with chronic HCV infection ANTIVIRAL RESEARCH
Letter2012 Liver stiffness correlates with Child-Pugh-Turcotte and MELD scores in HIV/hepatitis C virus-coinfected patients with cirrhosis LIVER INTERNATIONAL
Artículo2012 Liver stiffness predicts clinical outcome in human immunodeficiency virus/hepatitis C virus-coinfected patients with compensated liver cirrhosis HEPATOLOGY
Artículo2011 Liver toxicity of antiretroviral combinations including Fosamprenavir plus Ritonavir 1400/100mg once daily in HIV/Hepatitis C virus-coinfected patients AIDS Patient Care and ST Ds
Artículo2011 Twelve week post-treatment follow-up predicts sustained virological response to pegylated interferon and ribavirin therapy in HIV/hepatitis C virus co-infected patients JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2010 Changes in liver stiffness in patients with chronic hepatitis C with and without HIV co-infection treated with pegylated interferon plus ribavirin JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2010 Haart and the liver: friend or foe? EUROPEAN JOURNAL OF MEDICAL RESEARCH
Artículo2010 Prevalence and risk factors for abnormal liver stiffness in HIV-infected patients without viral hepatitis coinfection: role of didanosine ANTIVIRAL THERAPY
Revisión2009 Esteatosis hepática no alcohólica en la infección por el virus de la inmunodeficiencia humana MEDICINA CLINICA
Artículo2009 Insulin resistance is associated with liver stiffness in HIV/HCV co-infected patients GUT
Artículo2009 Insulin resistance is not a relevant predictor of sustained virological response to pegylated interferon plus ribavirin in HIV/HCV co-infected patients JOURNAL OF HEPATOLOGY
Artículo2009 Natural history of compensated hepatitis C virus-related cirrhosis in HIV-infected patients CLINICAL INFECTIOUS DISEASES
Artículo2008 Esteatosis hepática no alcohólica en la infección por VIH Revista Andaluza de Patología Digestiva
Artículo2008 High prevalence of hepatitis C virus infection among noninjecting drug users: association with sharing the inhalation implements of crack LIVER INTERNATIONAL
Letter2007 Coexistence of pyoderma gangrenosum and Sweet's syndrome in a patient with ulcerative colitis AMERICAN JOURNAL OF GASTROENTEROLOGY
Artículo2007 Low-level liver enzyme elevations during HAART are not associated with liver fibrosis progression among HIV/HCV-coinfected patients JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Revisión2007 Management of HCV-related end-stage liver disease in HIV-coinfected patients AIDS REVIEWS
Artículo2006 Antiretroviral therapy based on protease inhibitors as a protective factor against liver fibrosis progression in patients with chronic hepatitis C ANTIVIRAL THERAPY
Artículo2006 Incidence of and risk factors for insulin resistance in treatment-naive HIV-infected patients 48 weeks after starting highly active antiretroviral therapy ANTIVIRAL THERAPY
Artículo2006 Insulin resistance is not associated with liver fibrosis progression in HIV/hepatitis C virus-coinfected patients JOURNAL OF VIRAL HEPATITIS
Artículo2006 Survival and prognostic factors of HIV-infected patients with HCV-related end-stage liver disease AIDS
Artículo2005 Increased hepatocyte Fas expression and apoptosis in HIV and hepatitis C virus coinfection JOURNAL OF INFECTIOUS DISEASES
Artículo2005 Prevalencia de anticuerpos séricos frente a Bartonella spp. en una población sana del área sur de la provincia de Sevilla REVISTA CLINICA ESPANOLA
Artículo2004 Bilateral enophthalmos as a manifestation of HIV infection-related lipoatrophy HIV MEDICINE
Artículo2004 Effect of antiretroviral drugs on liver fibrosis in HIV-infected patients with chronic hepatitis C: harmful impact of nevirapine AIDS
Letter2004 Intoxicación digitálica secundaria a una alteración del metabolismo intestinal de la digoxina en una paciente tratada con claritromicina MEDICINA CLINICA
Letter2004 Prevalence of non-significant liver fibrosis and rate of fibrosis progression in HIV/hepatitis C virus-co-infected patients: still a role for liver biopsy? AIDS
Letter2004 Transient Budd-Chiari syndrome due to iatrogenic subcapsular fluid accumulation following thoracocentesis AMERICAN JOURNAL OF GASTROENTEROLOGY
El colectivo no tiene ningún proyecto asociado.
El colectivo no tiene ningún resultado de investigación asociado